2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$35.16+$0.17 (+0.49%)
Price as of Jun 23, 2026 3:16 PM EDT- $1.6BMarket Cap
- 144.69%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$35.16+$0.17 (+0.49%)
URGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.99 | ||
Change | +$1.42 (+4.23%) | ||
Open | $33.96 | ||
High | $35.35 | ||
Low | $33.70 | ||
Previous Close | $33.57 | ||
Volume | 643,467 | ||
30-Day Average Volume | 650,517 | ||
1-Week Change | 13.36% | ||
1-Month Change | 21.11% | ||
1-Year Change | 144.69% | ||
3-Year Change | 193.54% | ||
5-Year Change | 112.71% | ||
Fundamentals | |||
Shares Outstanding | 46.8M | ||
Total Assets | $253.7M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $51.0M | ||
Net Income | -$23.6M | ||
Free Cash Flow | -$45.4M | ||
EBIT | -$28.3M | ||
EBITDA | -$28.3M | ||
Net Working Capital | $186.8M | ||
EPS | -$0.47 | ||
Enterprise Value/EBITDA | -61 | ||
Enterprise Value/Revenue | 34 | ||
P/B | -13 | ||
P/E | -74 | ||
PEG | -6 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue